Miniprotein radioconjugate platform Discovery platform used in partnered development of tumor-targeting radiopharmaceuticals, including Aktis’ multi-target research collaboration with Lilly.
Visit productCosigns Received
Be the first Cosign
Put your name behind Miniprotein radioconjugate platform.
Add it to your Products I use list and share why you use it.